Precision Insights Podcast

Pharmacogenomics is like pharmacology on steroids

Adrijana Kekic, Pharmacogenomics Pharmacist and Associate Program Director for Outpatient Pharmacy at Mayo Clinic, joined us to talk about the role of pharmacists in delivering personalized care, and the role of technology in enabling PGx implementation at the point of care. You'll also learn about some challenges and exciting developments in personalized medicine.  

 

Pharmacogenomics is part of population health management

Richard (Curt) Dame, Vice President of Aon Health Solutions Practice, joined us to talk about the deployment of pharmacogenomics into popular health management programs, the successes he has seen through the members' health outcomes, and the future he thinks it has. 

Interoperability in healthcare: Is it living up to the hype?

Dave Wolfe, the founder and president of FusionRx, joined us to talk about the current healthcare interoperability landscape and the increasing role of pharmacogenetics (PGx).

 

How can pharmacogenetics be helpful to doctors?

Sue Paul, Founder and CEO of SyneRxgy Consulting joined us to talk about her experience implementing pharmacogenetic (PGx) information into the point of care and educating patients and healthcare providers about the principles and practical implications of PGx in primary care. 

 

 

Helping employers make informed decision about healthcare

Denise Giambalvo of the Midwest Business Group on Health (MBGH) joined us to talk about making informed decisions on healthcare strategy, the top most disabling illnesses and how employers are embracing the emergence of
precision medicine.

Patients and clinicians should be partners

Danny Sands MD, MPH of Beth Israel Deaconess Medical Center joined us to talk about how our health care system is not working as well as it should for patients and clinicians, nor for the government, employers, and insurance plans that pay for it.

The value of good health

Tom Parry President of the Integrated Benefits Institute (IBI), joined us for a conversation on the value of good health.

 

Emerging trends in precision medicine, pockets of adoption and organizations addressing business challenges facing the health care industry.

Carrie Hurwitz Williams, Principal at McKesson Ventures, joined us for a conversation on emerging trends in precision medicine, pockets of adoption and organizations addressing business challenges facing the health care industry.

‘A patient died right in front of me because they had the wrong medication. We need to stop practicing medicine like this

Bob Mehr is a business innovator and industry leader who began his career as a Compounding Pharmacist. Bob Mehr has been the President and CEO of Pure Integrative Pharmacy since 1999 opening 14 stores. His experience with precision prescribing goes beyond his practice and has had a tremendous impact on his own health.

Imagine being able to reprogram your cells to find the right medication for your heart.

Dr. Liam Brunham, Assistant Professor in the Department of Medicine at the University of British Columbia and a Principal Investigator at the UBC Centre for Heart and Lung Innovation join us for a conversation on adverse drug reactions, pharmacogenetics and iPSC.